Bio-Thera Solutions Ltd Working Capital to Net Assets Ratio

Latest as of June 2026: -492.9%

Bio-Thera Solutions Ltd working capital to net assets ratio. Bio-Thera Solutions Ltd (688177) has a Working Capital to Net Assets ratio of -492.9% as of June 2026. Working capital of CN¥-610.96 Million (current assets of CN¥1.14 Billion minus current liabilities of CN¥1.75 Billion) is measured against net assets of CN¥123.94 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Bio-Thera Solutions Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

-492.9%
Working Capital / Net Assets

Working Capital

CN¥-610.96 Million
CNY

Current Assets

CN¥1.14 Billion
CNY

Current Liabilities

CN¥1.75 Billion
CNY

Working Capital to Net Assets Ratio of Bio-Thera Solutions Ltd (2016–2025)

Working capital to net assets ratio of Bio-Thera Solutions Ltd from 2016 to 2025. This chart shows how Bio-Thera Solutions Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at -492.9%, reflecting working capital of CN¥-610.96 Million against net assets of CN¥123.94 Million CNY. See 688177 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Bio-Thera Solutions Ltd Working Capital to Net Assets Ratio by Year (2016–2025)

Bio-Thera Solutions Ltd working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Bio-Thera Solutions Ltd from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Bio-Thera Solutions Ltd.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 -108.7% CN¥-408.80 Million CN¥376.03 Million CN¥958.56 Million CN¥1.37 Billion ▼ -79.4 pp
2024 -29.3% CN¥-207.78 Million CN¥708.09 Million CN¥887.95 Million CN¥1.10 Billion ▼ -52.8 pp
2023 23.5% CN¥284.98 Million CN¥1.21 Billion CN¥1.01 Billion CN¥725.42 Million ▼ -15.3 pp
2022 38.8% CN¥623.76 Million CN¥1.61 Billion CN¥1.16 Billion CN¥538.50 Million ▼ -20.8 pp
2021 59.6% CN¥1.24 Billion CN¥2.09 Billion CN¥1.77 Billion CN¥526.04 Million ▲ +5.7 pp
2020 53.9% CN¥1.08 Billion CN¥2.01 Billion CN¥1.47 Billion CN¥385.36 Million ▲ +86.1 pp
2019 -32.1% CN¥-202.64 Million CN¥630.67 Million CN¥177.84 Million CN¥380.48 Million ▼ -32.6 pp
2018 0.5% CN¥4.13 Million CN¥801.32 Million CN¥217.35 Million CN¥213.22 Million ▲ +43.7 pp
2017 -43.2% CN¥-150.14 Million CN¥347.55 Million CN¥120.83 Million CN¥270.97 Million ▼ -72.9 pp
2016 29.7% CN¥158.91 Million CN¥534.43 Million CN¥332.23 Million CN¥173.32 Million —
pp = percentage points